{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:08:35Z","timestamp":1788916115496,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.molmet.2022.101639","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T23:05:16Z","timestamp":1668553516000},"page":"101639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice"],"prefix":"10.1016","volume":"66","author":[{"given":"Katrine D.","family":"Galsgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Elmelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian D.","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna B.","family":"Bomholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fcs\u00fcn S.","family":"Kizilkaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Ceutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna E.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannelouise","family":"Kissow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Winther-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper F.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette M.","family":"Rosenkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrine","family":"\u00d8rskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Christoffersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J.","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai J.","family":"Wewer Albrechtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.molmet.2022.101639_bib1","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2337\/dc15-1643","article-title":"Evaluation of efficacy and safety of the glucagon receptor antagonist LY2409021 in patients with type 2 diabetes: 12- and 24-week phase 2 studies","volume":"39","author":"Kazda","year":"2016","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.molmet.2022.101639_bib2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/dom.12904","article-title":"Treatment with the glucagon receptor antagonist LY2409021 increases ambulatory blood pressure in patients with type 2 diabetes","volume":"19","author":"Kazda","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"10.1016\/j.molmet.2022.101639_bib3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/dom.12958","article-title":"Treatment with LY2409021, a glucagon receptor antagonist, increases liver fat in patients with type 2 diabetes","volume":"19","author":"Guzman","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"10.1016\/j.molmet.2022.101639_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00000658-199108000-00007","article-title":"Metabolic consequences of (regional) total pancreatectomy","volume":"214","author":"Dresler","year":"1991","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.molmet.2022.101639_bib5","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1194\/jlr.M035592","article-title":"Effects of small interfering RNA-mediated hepatic glucagon receptor inhibition on lipid metabolism in db\/db mice","volume":"54","author":"Han","year":"2013","journal-title":"J Lipid Res"},{"issue":"7798","key":"10.1016\/j.molmet.2022.101639_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41586-020-2074-6","article-title":"Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis","volume":"579","author":"Perry","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2022.101639_bib7","first-page":"1240","article-title":"Effect of glucagon on the serum lipids in essential hyperlipemia and in hypercholesterolemia","volume":"11","author":"Amatuzio","year":"1962","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.molmet.2022.101639_bib8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cmet.2008.09.008","article-title":"The glucagon receptor is required for the adaptive metabolic response to fasting","volume":"8","author":"Longuet","year":"2008","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.molmet.2022.101639_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12432","article-title":"Efficacy and safety of glucagon-like peptide-1\/glucagon receptor co-agonist JNJ-64565111 in individuals with obesity without type 2 diabetes mellitus: a randomized dose-ranging study","volume":"11","author":"Alba","year":"2021","journal-title":"Clin Obes"},{"issue":"1","key":"10.1016\/j.molmet.2022.101639_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm.3761","article-title":"A\u00a0rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents","volume":"21","author":"Finan","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.molmet.2022.101639_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cmet.2021.12.005","article-title":"Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1\/GIP\/GCG receptor triagonist","volume":"34","author":"Bossart","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.molmet.2022.101639_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2022.07.013","article-title":"LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept","author":"Coskun","year":"2022","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.molmet.2022.101639_bib13","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1073\/pnas.0237106100","article-title":"Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice","volume":"100","author":"Gelling","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.molmet.2022.101639_bib14","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1210\/en.2015-1011","article-title":"Glucagon receptor blockade with a human antibody normalizes blood glucose in diabetic mice and monkeys","volume":"156","author":"Okamoto","year":"2015","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.molmet.2022.101639_bib15","doi-asserted-by":"crossref","first-page":"105296","DOI":"10.1016\/j.isci.2022.105296","article-title":"Opposing effects of chronic glucagon receptor agonism and antagonism on amino acids, hepatic gene expression, and alpha cells","volume":"25","author":"Elmelund","year":"2022","journal-title":"iScience"},{"issue":"17","key":"10.1016\/j.molmet.2022.101639_bib16","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1021\/jm7015599","article-title":"Novel glucagon receptor antagonists with improved selectivity over the glucose-dependent insulinotropic polypeptide receptor","volume":"51","author":"Kodra","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.molmet.2022.101639_bib17","doi-asserted-by":"crossref","DOI":"10.1152\/ajpendo.00122.2022","article-title":"Arginine-induced glucagon secretion and glucagon-induced enhancement of amino acid catabolism are not influenced by ambient glucose levels in mice","author":"Maruszczak","year":"2022","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.molmet.2022.101639_bib18","doi-asserted-by":"crossref","first-page":"E302","DOI":"10.1152\/ajpendo.00119.2016","article-title":"Dynamics of glucagon secretion in mice and rats revealed using a validated sandwich ELISA for small sample volumes","volume":"311","author":"Wewer Albrechtsen","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.molmet.2022.101639_bib19","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol"},{"key":"10.1016\/j.molmet.2022.101639_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101080","article-title":"Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis","volume":"42","author":"Winther-Sorensen","year":"2020","journal-title":"Mol Metab"},{"issue":"1","key":"10.1016\/j.molmet.2022.101639_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat Genet"},{"issue":"D1","key":"10.1016\/j.molmet.2022.101639_bib22","doi-asserted-by":"crossref","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","article-title":"The Gene Ontology resource: enriching a GOld mine","volume":"49","author":"Gene Ontology","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.molmet.2022.101639_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.molmet.2022.101639_bib24","series-title":"GO.db: a set of annotation maps describing the entire Gene Ontology","author":"Carlson","year":"2022"},{"issue":"3","key":"10.1016\/j.molmet.2022.101639_bib25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1194\/jlr.M400440-JLR200","article-title":"Sixteen hours of fasting differentially affects hepatic and muscle insulin sensitivity in mice","volume":"46","author":"Heijboer","year":"2005","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.molmet.2022.101639_bib26","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1101\/gad.891301","article-title":"SREBP cleavage-activating protein (SCAP) is required for increased lipid synthesis in liver induced by cholesterol deprivation and insulin elevation","volume":"15","author":"Matsuda","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.molmet.2022.101639_bib27","series-title":"Lipoids of the fasting mouse. 1. The relation between carcass lipids and liver lipids","first-page":"897","volume":"139","author":"Hodge","year":"1941"},{"key":"10.1016\/j.molmet.2022.101639_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101080","article-title":"Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis","volume":"42","author":"Winther-S\u00f8rensen","year":"2020","journal-title":"Mol Metab"},{"issue":"5","key":"10.1016\/j.molmet.2022.101639_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2337\/diabetes.24.5.502","article-title":"Modulation of fatty acid metabolism by glucagon in man. I. Effects in normal subjects","volume":"24","author":"Schade","year":"1975","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2022.101639_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0005-2760(88)90283-4","article-title":"Effects of chronic glucagon administration on cholesterol and bile acid metabolism","volume":"963","author":"Guettet","year":"1988","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.molmet.2022.101639_bib31","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF02536072","article-title":"Effect of chronic glucagon administration on lipoprotein composition in normally fed, fasted and cholesterol-fed rats","volume":"26","author":"Guettet","year":"1991","journal-title":"Lipids"},{"issue":"1","key":"10.1016\/j.molmet.2022.101639_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/jn\/121.1.24","article-title":"Effect of chronic glucagon administration on the metabolism of triacylglycerol-rich lipoproteins in rats fed a high sucrose diet","volume":"121","author":"Guettet","year":"1991","journal-title":"J Nutr"},{"key":"10.1016\/j.molmet.2022.101639_bib33","doi-asserted-by":"crossref","first-page":"18664","DOI":"10.1073\/pnas.1008734107","article-title":"Light at night increases body mass by shifting the time of food intake","volume":"107","author":"Fonken","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.molmet.2022.101639_bib34","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3181\/00379727-146-38254","article-title":"Glucagon and plasma lipoprotein lipase","volume":"146","author":"Caren","year":"1974","journal-title":"Proc Soc Exp Biol Med"},{"issue":"1 Pt 2","key":"10.1016\/j.molmet.2022.101639_bib35","first-page":"R160","article-title":"Glucagon stimulation of brown adipose tissue growth and thermogenesis","volume":"252","author":"Billington","year":"1987","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.molmet.2022.101639_bib36","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0165-1838(95)00007-K","article-title":"Increased muscle sympathetic nerve activity after glucagon administration in man","volume":"54","author":"Takayama","year":"1995","journal-title":"Journal of the Autonomic Nervous System"},{"issue":"1\u20132","key":"10.1016\/j.molmet.2022.101639_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mce.2009.08.031","article-title":"Sensory and sympathetic nervous system control of white adipose tissue lipolysis","volume":"318","author":"Bartness","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.molmet.2022.101639_bib38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1042\/bj2700803","article-title":"Contribution of glycerol and alanine to basal hepatic glucose production in the genetically obese (fa\/fa) rat","volume":"270","author":"Terrettaz","year":"1990","journal-title":"Biochem J"},{"issue":"11","key":"10.1016\/j.molmet.2022.101639_bib39","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1194\/jlr.M060897","article-title":"Glucagon receptor antagonism induces increased cholesterol absorption","volume":"56","author":"Guan","year":"2015","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.molmet.2022.101639_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/CIRCRESAHA.118.313648","article-title":"Hepatic glucagon signaling regulates PCSK9 and low-density lipoprotein cholesterol","volume":"124","author":"Spolitu","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.molmet.2022.101639_bib41","first-page":"938","article-title":"Glucagon and cholesterol metabolism","volume":"9","author":"Caren","year":"1960","journal-title":"Metabolism"},{"issue":"9","key":"10.1016\/j.molmet.2022.101639_bib42","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.3168\/jds.S0022-0302(03)73886-7","article-title":"Effects of exogenous glucagon on lipids in lipoproteins and liver of lactating dairy cows","volume":"86","author":"Bobe","year":"2003","journal-title":"J Dairy Sci"},{"issue":"10","key":"10.1016\/j.molmet.2022.101639_bib43","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.3168\/jds.S0022-0302(03)73915-0","article-title":"Potential treatment of fatty liver with 14-day subcutaneous injections of glucagon","volume":"86","author":"Bobe","year":"2003","journal-title":"J Dairy Sci"},{"issue":"1","key":"10.1016\/j.molmet.2022.101639_bib44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0005-2760(85)90251-6","article-title":"Effects of hormones and pyruvate on the rates of secretion of very-low-density lipoprotein triacylglycerol and cholesterol by rat hepatocytes","volume":"833","author":"Pullinger","year":"1985","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.molmet.2022.101639_bib45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/bj2640093","volume":"264","author":"Pegorier","year":"1989","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.molmet.2022.101639_bib46","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0021-9258(19)50832-8","article-title":"The effect of hyperglycemic-glycogenolytic factor on fat metabolism of liver","volume":"206","author":"Haugaard","year":"1954","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.molmet.2022.101639_bib47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/bj2690409","volume":"269","author":"Prip-Buus","year":"1990","journal-title":"Biochem J"},{"key":"10.1016\/j.molmet.2022.101639_bib48","article-title":"Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.molmet.2022.101639_bib49","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1210\/endo-98-6-1550","article-title":"A\u00a0fast in\u00a0vitro effect of glucocorticoids on hepatic lipolysis","volume":"98","author":"Divakaran","year":"1976","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.molmet.2022.101639_bib50","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nature Genet"},{"issue":"5","key":"10.1016\/j.molmet.2022.101639_bib51","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep4.1171","article-title":"Coding variants in PNPLA3 and TM6SF2 are risk factors for hepatic steatosis and elevated serum alanine aminotransferases caused by a glucagon receptor antagonist","volume":"2","author":"Guzman","year":"2018","journal-title":"Hepatol Commun"},{"issue":"9","key":"10.1016\/j.molmet.2022.101639_bib52","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"A\u00a0sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis","volume":"285","author":"He","year":"2010","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.molmet.2022.101639_bib53","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"Kumari","year":"2012","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.molmet.2022.101639_bib54","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.metabol.2014.06.016","article-title":"Shifts in dietary carbohydrate-lipid exposure regulate expression of the non-alcoholic fatty liver disease-associated gene PNPLA3\/adiponutrin in mouse liver and HepG2 human liver cells","volume":"63","author":"Hao","year":"2014","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.molmet.2022.101639_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01213680","article-title":"Effect of insulin on glucagon enhanced lipolysis in\u00a0vitro","volume":"5","author":"Lefebvre","year":"1969","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.molmet.2022.101639_bib56","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1210\/endo-113-1-270","article-title":"Studies of the biological effect and degradation of glucagon in the rat perifused isolated adipose cell","volume":"113","author":"Heckemeyer","year":"1983","journal-title":"Endocrinology"},{"key":"10.1016\/j.molmet.2022.101639_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110696","article-title":"Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes","volume":"503","author":"Pereira","year":"2020","journal-title":"Mol Cell Endocrinol"},{"issue":"Supplement 1","key":"10.1016\/j.molmet.2022.101639_bib58","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.2337\/db20-1914-P","article-title":"1914-P: prolonged (12-hour) glucagon infusion stimulates adipocyte lipolysis and inflammation in\u00a0vivo in humans","volume":"69","author":"Tripathy","year":"2020","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.molmet.2022.101639_bib59","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1113\/jphysiol.1966.sp008088","article-title":"The effect of propranalol on the calorigenic response in brown adipose tissue of new-born rabbits to catecholamines, glucagon, corticotrophin and cold exposure","volume":"187","author":"Heim","year":"1966","journal-title":"J Physiol"},{"issue":"5","key":"10.1016\/j.molmet.2022.101639_bib60","first-page":"R1674","article-title":"Apparent thermogenic effect of injected glucagon is not due to a direct effect on brown fat cells","volume":"275","author":"Dicker","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.molmet.2022.101639_bib61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molmet.2019.01.011","article-title":"The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice","volume":"22","author":"Beaudry","year":"2019","journal-title":"Mol Metab"},{"issue":"4","key":"10.1016\/j.molmet.2022.101639_bib62","first-page":"e141323","article-title":"Glucagon receptor signaling regulates weight loss via central KLB receptor complexes","volume":"6","author":"Nason","year":"2021","journal-title":"JCI Insight"},{"issue":"Supplement 1","key":"10.1016\/j.molmet.2022.101639_bib63","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.2337\/db20-1908-P","article-title":"1908-P: glucagon receptor expression evaluated by antibody-dependent and -independent approaches","volume":"69","author":"Kjeldsen","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2022.101639_bib64","doi-asserted-by":"crossref","DOI":"10.2337\/db21-1166","article-title":"The GIPR is predominantly localized to non-adipocyte cell types within white adipose tissue","author":"Campbell","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.molmet.2022.101639_bib65","series-title":"Glucagon receptor signaling at white adipose tissue does not regulate lipolysis","author":"Vasileva","year":"2022"},{"issue":"5","key":"10.1016\/j.molmet.2022.101639_bib66","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2337\/db19-1216","article-title":"The limited role of glucagon for ketogenesis during fasting or in response to SGLT2 inhibition","volume":"69","author":"Capozzi","year":"2020","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.molmet.2022.101639_bib67","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/db12-0797","article-title":"Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia","volume":"62","author":"Tan","year":"2013","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.molmet.2022.101639_bib68","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.2337\/db14-0242","article-title":"Coinfusion of low-dose GLP-1 and glucagon in man results in a reduction in food intake","volume":"63","author":"Cegla","year":"2014","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.molmet.2022.101639_bib69","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.2337\/db22-0313","article-title":"Impaired glucagon-mediated suppression of VLDL-triglyceride secretion in individuals with metabolic dysfunction-associated fatty liver disease (MAFLD)","volume":"71","author":"Heeb\u00f8ll","year":"2022","journal-title":"Diabetes"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877822002083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877822002083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:34:37Z","timestamp":1761957277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877822002083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":69,"alternative-id":["S2212877822002083"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2022.101639","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon receptor antagonism impairs and glucagon receptor agonism enhances triglycerides metabolism in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2022.101639","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101639"}}